Pinealon Reference

Plain English

What it is

Pinealon is a lab-made peptide, which means a very short chain of amino acids (the building blocks of proteins). It came out of a Russian research program that studies aging. It is not an approved medicine. It is sold as a research chemical, not as a regulated treatment for any condition.

What people use it for

In the peptide community, people use it hoping to support brain health, memory, and healthy aging, often pairing it with another peptide called Epitalon. These are personal goals people chase on their own, not proven medical outcomes.

What the science shows

Almost all of the research comes from Russian labs and was done in animals and cells, not in solid human studies. That early work hints it might protect brain cells from stress, but independent studies in people outside Russia are basically missing. So the brain and longevity claims are not proven.

The catch

Because there is no approved Pinealon product, no health agency checks what is actually inside what people buy, and long-term safety in humans is unknown. The popular framing as a brain-boosting longevity peptide runs well ahead of the thin, mostly Russian evidence.

Reference summary

Published work is dominated by Russian peptide-bioregulator literature with small mechanistic and animal studies. Independent peer-reviewed human clinical evidence is limited.

Regulatory and posture

Categories

Longevity, Cognitive

Aliases

Khavinson tetrapeptide, Glu-Asp-Arg

Evidence posture

preclinical - Mostly Russian peptide-bioregulator literature with limited independent human clinical evidence. Community framing as a longevity nootropic outruns the published data.

Regulatory status

No FDA-approved Pinealon drug label. Pinealon is a tetrapeptide bioregulator developed within the Khavinson Russian peptide-bioregulator program, sold as a research compound or Russian-market dietary preparation rather than as an FDA-approved drug.

Content review status

research reference